MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
CytomX Therapeutics, Inc.

CTMX

#2162
CytomX Therapeutics, Inc.
5.37
-0.37%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
5.37
5.37
Intervallo Annuale
0.40
6.35
Variazione giornaliera
-0.37%
Variazione Mensile
-9.60%
Variazione di 6 mesi
+156.94%
Variazione Annuale
+701.49%
Chiusura Precedente
5.39
Open
5.37
Bid
Ask
Low
5.37
High
5.37
Volume
86
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. CTMX
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Notizie

Zacks Zacks
NVCR CTMX
l’altro ieri, 17:15
NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates
Zacks Zacks
ABCL CTMX
2026.02.25
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates
Investing Investing
CTMX
2026.02.12
CytomX al Summit Guggenheim: Percorso promettente per il trattamento del CRC
Investing Investing
CTMX
2026.02.12
CytomX at Guggenheim Summit: Promising CRC Treatment Path
Zacks Zacks
QGEN CTMX
2026.02.04
Qiagen (QGEN) Meets Q4 Earnings Estimates
Investing Investing
CTMX
2026.02.03
CytomX Therapeutics stock hits 52-week high at 6.16 USD
Zacks Zacks
RGNX CTMX
2026.01.30
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?
Zacks Zacks
QGEN CTMX
2026.01.21
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?
Investing Investing
CTMX
2026.01.20
Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data
Zacks Zacks
MRK ALKS CTMX
2026.01.19
CytomX Stock Rises 31% in a Month: Here's What You Should Know
Seeking Alpha Seeking Alpha
CTMX
2026.01.14
CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha Seeking Alpha
CTMX
2025.12.24
CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX)

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd